Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed Dec 3, 2012 · 10-Q · 156 days after period end · 0001144204-12-066091
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $16.30K | $279.18K | $157.70K |
| Net Income | -$134.27K | -$598.05K | -$1.35M |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Dec 3, 2012 · 156 d after period end
